ERS 2023: In-depth report
This in-depth report provides an overview of the latest advances in the diagnosis, treatment and management of chronic obstructive pulmonary disease and interstitial lung disease presented at ERS 2023.
Developed by:
Springer Healthcare
Register now to read the ERS 2023 report
Financial disclosure
This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.
Disclaimer
©Springer Healthcare 2023. This content has been independently selected and developed by Springer Healthcare and funded by F. Hoffmann-La Roche Ltd. This content is not intended for use by healthcare professionals in the UK, US or Australia. Inclusion or exclusion of any product does not imply its use is either advocated or rejected. Use of trade names is for product identification only and does not imply endorsement. Opinions expressed do not reflect the views of Springer Healthcare. Springer Healthcare assumes no responsibility for any injury or damage to persons or property arising out of, or related to, any use of the material or to any errors or omissions. Please consult the latest prescribing information from the manufacturer for any products mentioned in this material.
